导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -17.60% | 968/1050 |
| 近一周 | -3.01% | 796/1104 |
| 近一月 | -3.11% | 418/1102 |
| 近一季 | 1.14% | 251/1092 |
| 近半年 | -12.57% | 850/1070 |
| 近一年 | -24.39% | 959/1018 |
| 近两年 | -6.03% | 912/926 |
| 近三年 | -26.12% | 795/833 |
| 成立以来 | 224.50% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.67% 992/1070 |
-14.53% 1012/1101 |
- - |
- - |
| 2025 | -4.17% 943/1065 |
0.61% 755/1014 |
-7.30% 993/1038 |
8.83% 867/1050 |
-5.59% 724/1065 |
| 2024 | 4.30% 449/1011 |
5.81% 90/960 |
-6.50% 716/983 |
12.97% 383/991 |
-6.68% 764/1011 |
| 2023 | -14.81% 516/952 |
3.29% 421/880 |
-10.10% 775/895 |
-0.77% 106/915 |
-7.54% 729/952 |
| 2022 | -13.66% 145/867 |
-22.95% 666/773 |
22.31% 11/806 |
-9.70% 228/845 |
1.46% 360/867 |
| 2021 | -11.19% 491/740 |
-7.03% 419/580 |
5.08% 467/659 |
-11.61% 544/704 |
2.85% 313/740 |
| 2020 | 72.52% 134/554 |
-8.60% 365/419 |
21.47% 261/466 |
20.30% 55/517 |
29.17% 40/554 |
| 2019 | 71.36% 33/410 |
41.65% 43/1149 |
10.37% 14/1231 |
3.48% 233/390 |
5.93% 310/410 |
| 2018 | -23.47% 125/349 |
- - |
- - |
- - |
-15.85% 909/1080 |
| 2017 | 64.97% 1/285 |
- - |
- - |
- - |
- - |
| 2016 | 7.21% 9/205 |
- - |
- - |
- - |
- - |
| 2015 | 26.85% 50/151 |
- - |
- - |
- - |
- - |
| 2014 | 8.46% 20/24 |
- - |
- - |
- - |
- - |
| 2013 | 17.40% 9/21 |
- - |
- - |
- - |
- - |
| 2012 | -2.28% 147/157 |
- - |
- - |
- - |
- - |
| 2011 | -15.06% 7/102 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 易方达消费行业股票 VS. 东吴新产业精选股票A(580008) |